BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Thermage, Inc. Receives Unsolicited Acquisition Proposal


8/21/2008 8:11:55 AM

HAYWARD, Calif., Aug. 20 /PRNewswire-FirstCall/ -- Thermage, Inc. announced today that it has received a revised unsolicited, non-binding proposal from a third party for an alternative transaction to Thermage's pending merger with Reliant Technologies, Inc. The unsolicited, non-binding proposal calls for the acquisition of all of the outstanding shares of Thermage for a price of $5.50 per share in cash or a combination of cash and stock, subject to due diligence and negotiation of a definitive agreement.

The Thermage Board of Directors will consider the unsolicited, non-binding proposal in a manner consistent with its fiduciary duties and in accordance with its obligations under its merger agreement with Reliant. Following its review of the unsolicited, non-binding proposal, Thermage's board will respond in due course.

The merger agreement with Reliant prohibits Thermage from entering into discussions with a third party concerning an alternative transaction unless the Thermage Board of Directors reasonably determines in good faith that the acquisition proposal constitutes or is reasonably likely to lead to a superior proposal and that the failure to take such action would reasonably be expected to be a breach of its fiduciary duties under Delaware law.

Additional Information and Where You Can Find It

This communication may be deemed to be solicitation material in respect of the proposed transaction between Thermage and Reliant. In connection with the transaction, Thermage filed a registration statement on Form S-4 with the SEC containing a proxy statement/prospectus/ information statement. The proxy statement/prospectus/information statement will be mailed to the stockholders of Thermage and Reliant. Investors and security holders of Thermage and Reliant are urged to read the proxy statement/ prospectus/information statement because it contains important information about Thermage, Reliant and the proposed transaction. The proxy statement/ prospectus/ information statement, and any other documents filed by Thermage with the SEC, may be obtained free of charge at the SEC's web site at http://www.sec.gov. In addition, investors and security holders may obtain free copies of the documents filed with the SEC by Thermage by contacting Thermage Investor Relations by e-mail at IR@thermage.com or by telephone at (510) 259-7117. Investors and security holders are urged to read the proxy statement/prospectus/information statement and the other relevant materials before making any voting or investment decision with respect to the proposed transaction with Reliant.

Thermage and its respective directors and executive officers may be deemed to be participants in the solicitation of proxies from its stockholders in favor of the proposed transaction with Reliant. Information about the directors and executive officers of Thermage is available in the proxy statement/prospectus/information statement.

CONTACT: Jack Glenn, Chief Financial Officer, +1-510-786-6890 of Thermage,
Inc.; or Investors, Jenifer Kirtland, +1-415-896-6820, or Media,
Christopher Gale, +1-646-201-5431, both of EVC Group, Inc., for Thermage,
Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES